In a cohort of 105 patients, those receiving grafts with higher CD8+ γδ T cell numbers experienced higher incidence of grade 2–4 acute GVHD, but in parallel, a perhaps predictable lower incidence of relapse (105). This evidence concerns the gene CD8A and acute graft versus host disease.